Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gustafsson

Showing results (311-320 of 386) with videos related to

Pageof 39
Sort By:
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 18, 2007
Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural TanzaniaJ Eriksen, S Mwankusye, S Mduma, et al.
Tropical Medicine & International Health : TM & IH|September 28, 2005
Adoption of the new antimalarial drug policy in Tanzania--a cross-sectional study in the communityJaran Eriksen, Stephen E D Nsimba, Omary M S Minzi, et al.
Basic & Clinical Pharmacology & Toxicology|November 9, 2017
Policy Change and the National Essential Medicines List Development Process in Brazil between 2000 and 2014: Has the Essential Medicine Concept been Abandoned?Claudia G S Osorio-de-Castro, Thiago B Azeredo, Vera L E Pepe, et al.
Alcoholism, Clinical and Experimental Research|July 25, 2003
A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependenceJ Balldin, M Berglund, S Borg, et al.
Clinical Pharmacology and Therapeutics|August 1, 1995
Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteersP Hartvig, J Valtysson, K J Lindner, et al.
European Journal of Clinical Pharmacology|February 12, 2009
SFINX-a drug-drug interaction database designed for clinical decision support systemsYlva Böttiger, Kari Laine, Marine L Andersson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2011
Nonlinear structured-illumination microscopy with a photoswitchable protein reveals cellular structures at 50-nm resolutionE Hesper Rego, Lin Shao, John J Macklin, et al.
British Journal of Clinical Pharmacology|November 18, 2009
A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in UgandansJackson K Mukonzo, Daniel Röshammar, Paul Waako, et al.
HIV Medicine|November 24, 2011
Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected UgandansS Nanzigu, J Eriksen, F Makumbi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case SeriesKlara Sondén, Katja Wyss, Irina Jovel, et al.
Pageof 39

Showing results (311-320 of 386) with videos related to

Sort By:
Pageof 39
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 18, 2007
Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural TanzaniaJ Eriksen, S Mwankusye, S Mduma, et al.
Tropical Medicine & International Health : TM & IH|September 28, 2005
Adoption of the new antimalarial drug policy in Tanzania--a cross-sectional study in the communityJaran Eriksen, Stephen E D Nsimba, Omary M S Minzi, et al.
Basic & Clinical Pharmacology & Toxicology|November 9, 2017
Policy Change and the National Essential Medicines List Development Process in Brazil between 2000 and 2014: Has the Essential Medicine Concept been Abandoned?Claudia G S Osorio-de-Castro, Thiago B Azeredo, Vera L E Pepe, et al.
Alcoholism, Clinical and Experimental Research|July 25, 2003
A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependenceJ Balldin, M Berglund, S Borg, et al.
Clinical Pharmacology and Therapeutics|August 1, 1995
Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteersP Hartvig, J Valtysson, K J Lindner, et al.
European Journal of Clinical Pharmacology|February 12, 2009
SFINX-a drug-drug interaction database designed for clinical decision support systemsYlva Böttiger, Kari Laine, Marine L Andersson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2011
Nonlinear structured-illumination microscopy with a photoswitchable protein reveals cellular structures at 50-nm resolutionE Hesper Rego, Lin Shao, John J Macklin, et al.
British Journal of Clinical Pharmacology|November 18, 2009
A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in UgandansJackson K Mukonzo, Daniel Röshammar, Paul Waako, et al.
HIV Medicine|November 24, 2011
Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected UgandansS Nanzigu, J Eriksen, F Makumbi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case SeriesKlara Sondén, Katja Wyss, Irina Jovel, et al.
Pageof 39